2022 Annual Meeting | S1 - Sleep: Want to Hear the Latest?
Program Materials Program Evaluations
| 01:00 PM - 01:24 PM PDT | Speaker |
2022 Sleep Science Award: This award recognizes distinguished academic contributions by neurologists to the field of sleep medicine or the contributions of non-neurologists to the interface area of sleep neurology.
Louis J. Ptacek, MD |
| 01:00 PM - 01:00 PM PDT | Speaker |
walk in slides
J. Kent Werner, Jr., MD, PhD |
| 01:24 PM - 01:36 PM PDT | Speaker |
2022 Wayne A. Hening Sleep Medicine Investigator Award: This award recognizes scientific contributions in sleep from promising young investigators.
J. Kent Werner, Jr., MD, PhD |
| 01:36 PM - 01:48 PM PDT | Abstract |
004 - Longitudinal 123I-FP-CIT SPECT Imaging in Isolated REM Sleep Behavior Disorder
Toji Miyagawa, MD, PhD |
| 01:48 PM - 02:00 PM PDT | Abstract |
005 - Poor sleep quality is associated with elevated exosomal inflammatory cytokines in warfighters with chronic mild TBI
Bryson Hewins |
| 02:00 PM - 02:12 PM PDT | Abstract |
006 - Acute blood biomarkers predict chronic insomnia trajectories following traumatic brain injury: A TRACK-TBI study
J. Kent Werner, Jr., MD, PhD |
| 02:12 PM - 02:24 PM PDT | Abstract |
007 - Impairment in Functioning and Quality of Life in Patients With Idiopathic Hypersomnia: the Real World Idiopathic Hypersomnia Outcomes Study (ARISE)
Logan D. Schneider, MD |
| 02:24 PM - 02:36 PM PDT | Abstract |
008 - Cardiovascular Burden of Narcolepsy Disease (CV-BOND): a Real-World Evidence Study
Rami Ben-Joseph, PhD |
| 02:36 PM - 02:48 PM PDT | Abstract |
009 - Safety and pharmacodynamics of a single infusion of TAK-925 in adults with idiopathic hypersomnia
Emmanuel Mignot, MD, PhD |
| 02:48 PM - 03:00 PM PDT | Abstract |
010 - Good Night, Sleep Tight, Don’t Let the Sleep Disturbances Bite
Alexander Poulakis |
| No disclosure on file | |
| Michael Silber, MB, ChB, FAAN | Dr. Silber has received publishing royalties from a publication relating to health care. Dr. Silber has received personal compensation in the range of $500-$4,999 for serving as a Topic writer with UpToDate. |
| Phyllis C. Zee, MD, PhD | Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Aventis. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony Biosciences. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals Inc.. Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. The institution of Dr. Zee has received research support from National Institutes of Health. The institution of Dr. Zee has received research support from Vanda. Dr. Zee has received intellectual property interests from a discovery or technology relating to health care. Dr. Zee has received intellectual property interests from a discovery or technology relating to health care. Dr. Zee has received publishing royalties from a publication relating to health care. |
| Josephine Pierce Pucci, MD | Ms. Pucci has a non-compensated relationship as a co-founder with Headway Foundation that is relevant to AAN interests or activities. |
| Julie A. Fields, PhD | The institution of Dr. Fields has received research support from National Institutes of Health. The institution of Dr. Fields has received research support from Patient-Centered Outcomes Research Institute. |
| Rodolfo Savica, MD, PhD, FAAN | The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc. |
| Nancy R. Foldvary-Schaefer, DO, FAAN | Dr. Foldvary-Schaefer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Suven. The institution of Dr. Foldvary-Schaefer has received research support from Takeda. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care. |
| Richard K. Bogan, MD | Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony. Dr. Bogan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. Dr. Bogan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bogan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Harmony. Dr. Bogan has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz. The institution of Dr. Bogan has received research support from Jazz Pharmaceuticals. The institution of Dr. Bogan has received research support from Harmony . The institution of Dr. Bogan has received research support from Philips. The institution of Dr. Bogan has received research support from Eisai. The institution of Dr. Bogan has received research support from Fresca. The institution of Dr. Bogan has received research support from Avadel. The institution of Dr. Bogan has received research support from Takeda. The institution of Dr. Bogan has received research support from Suven. The institution of Dr. Bogan has received research support from Axsome. Dr. Bogan has received intellectual property interests from a discovery or technology relating to health care. Dr. Bogan has a non-compensated relationship as a Chair with National Sleep Foundation that is relevant to AAN interests or activities. |
| Bradley F. Boeve, MD, FAAN | Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care. |
| Leah K. Forsberg, PhD | Ms. Forsberg has nothing to disclose. |
| Scott Przybelski | No disclosure on file |
| Douglas S. Fuller | Mr. Fuller has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Mr. Fuller has stock in Jazz Pharmaceuticals. |
| Geoffrey Manley, MD, PhD | The institution of Dr. Manley has received research support from NIH-NINDS. The institution of Dr. Manley has received research support from US Department of Defense. The institution of Dr. Manley has received research support from US Department of Defense/MTEC. The institution of Dr. Manley has received research support from One Mind. The institution of Dr. Manley has received research support from Neurotrauma Sciences, LLC. The institution of Dr. Manley has received research support from NFL Scientific Advisory Board. |
| Ramon R. Diaz-Arrastia, MD, PhD, FAAN | Dr. Diaz-Arrastia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ischemix, Inc. Dr. Diaz-Arrastia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pinteon Therapeutics. Dr. Diaz-Arrastia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BrainBox, LLC. Dr. Diaz-Arrastia has received stock or an ownership interest from BrainBox, LLC. Dr. Diaz-Arrastia has received stock or an ownership interest from NovaSignal . Dr. Diaz-Arrastia has received stock or an ownership interest from Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense. |
| Ronald C. Petersen, MD, PhD, FAAN | Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nestle. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities. |
| Jennifer Lin, MD | Ms. Lin has nothing to disclose. |
| Val J. Lowe, MD | Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals. |
| Kimbra L. Kenney, MD, FAAN | Dr. Kenney has nothing to disclose. |
| Melissa Naylor | Ms. Naylor has received personal compensation for serving as an employee of Takeda. Ms. Naylor has received stock or an ownership interest from Takeda. |
| Timothy Lesnick | No disclosure on file |
| Tina Olsson, PhD | Dr. Olsson has received personal compensation for serving as an employee of Takeda. |
| Bryson Hewins | Mr. Hewins has nothing to disclose. |
| Laura Allen, NP | Ms. Allen has nothing to disclose. |
| Alexander Poulakis | Mr. Poulakis has nothing to disclose. |
| David T. Jones, MD | Dr. Jones has received intellectual property interests from a discovery or technology relating to health care. |
| David S. Knopman, MD, FAAN | Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH. |
| Raquel Gardner, MD | Dr. Gardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BrainBox. The institution of Dr. Gardner has received research support from NIH. The institution of Dr. Gardner has received research support from DoD. |
| Toji Miyagawa, MD, PhD | Dr. Miyagawa has nothing to disclose. |
| Stuart McCarter, MD | Dr. McCarter has received research support from NIH. |
| Andrew Krystal | No disclosure on file |
| Ragy Saad | No disclosure on file |
| Logan D. Schneider, MD | Dr. Schneider has received personal compensation for serving as an employee of Alphabet, Inc. Dr. Schneider has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avadel Pharmaceuticals. Dr. Schneider has received intellectual property interests from a discovery or technology relating to health care. |
| Emmanuel Mignot, MD, PhD | Dr. Mignot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Mignot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceutical. Dr. Mignot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharmaceuticals, Inc. . Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for EcoR1. Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for ApneaCo. Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai Pharmaceuticals. Dr. Mignot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Centessa . |
| Jed Black, MD | Jed Black, MD has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Jed Black, MD has stock in Jazz Pharmaceuticals. Jed Black, MD has stock in . |
| Rami Ben-Joseph, PhD | Dr. Ben-Joseph has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Ben-Joseph has stock in Jazz Pharmaceuticals. |
| Joseph T. Giacino, PhD | Dr. Giacino has nothing to disclose. |
| Kejal Kantarci, MD | The institution of Dr. Kantarci has received research support from Eli Lilly. The institution of Dr. Kantarci has received research support from NIH. The institution of Dr. Kantarci has received research support from ADDF. |
| Tanis J. Ferman | Ms. Ferman has nothing to disclose. |
| Virend Somers | No disclosure on file |
| Erik K. St. Louis, MD | Dr. St. Louis has received publishing royalties from a publication relating to health care. Dr. St. Louis has received publishing royalties from a publication relating to health care. |
| Wayne Macfadden, MD, PT | Dr. Macfadden has received personal compensation for serving as an employee of Jazz pharma. Dr. Macfadden has stock in Jazz pharma. |
| Aatif M. Husain, MD | Dr. Husain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Husain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlackThorn Pharmaceuticals. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharmaceuiticals. Dr. Husain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Marinus Pharmaceuticals. Dr. Husain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis Pharmaceuitcals. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Pharmaceuticals. Dr. Husain has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Husain has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . Dr. Husain has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for International Federation of Clinical Neurophysiology. Dr. Husain has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Clinical Neurophysiology Society. Dr. Husain has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. The institution of Dr. Husain has received research support from Marinus Pharmaecuticals. Dr. Husain has received publishing royalties from a publication relating to health care. Dr. Husain has received publishing royalties from a publication relating to health care. Dr. Husain has received publishing royalties from a publication relating to health care. Dr. Husain has a non-compensated relationship as a Vice Chair of CNP MOC committee with American Board of Psychiatry and Neurology that is relevant to AAN interests or activities. |
| J. Kent Werner, Jr., MD, PhD | Dr. Werner has received personal compensation for serving as an employee of Cogentis Therapeutics. Dr. Werner has stock in Cogentis Therapeutics. Dr. Werner has received intellectual property interests from a discovery or technology relating to health care. Dr. Werner has received intellectual property interests from a discovery or technology relating to health care. Dr. Werner has received personal compensation in the range of $100,000-$499,999 for serving as a Neurologist with United States Navy. Dr. Werner has received personal compensation in the range of $50,000-$99,999 for serving as a CEO / CoFounder with Cogentis Therapeutics. |
| Hugo Botha, MD | Dr. Botha has received research support from NIH. |
| Jonathan Graff-Radford, MD, FAAN | Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics. |
| Walter Kremers | No disclosure on file |
| Vijay K. Ramanan, MD, PhD | The institution of Dr. Ramanan has received research support from the National Institutes of Health. The institution of Dr. Ramanan has received research support from the Mangurian Foundation for Lewy Body Disease Research. The institution of Dr. Ramanan has received research support from as part of clinical trials sponsored by the Alzheimer's Association, Eisai, the Alzheimer's Treatment and Research Institute at USC, and Transposon Therapeutics, Inc.. The institution of Dr. Ramanan has received research support from Medscape. Dr. Ramanan has received personal compensation in the range of $500-$4,999 for serving as a Conference Speaker/Organizer (Honoraria) with AANI. |
| Michael Ibarra, MD | Dr. Ibarra has nothing to disclose. |
| Todd J. Swick, MD, FAAN | Dr. Swick has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Swick has received stock or an ownership interest from Takeda Pharmaceuticals. |
| Helene A. Emsellem, MD | The institution of Dr. Emsellem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GuidePoint Consulting. The institution of Dr. Emsellem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda Pharmaceuticals. The institution of Dr. Emsellem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony Bioscience. The institution of Dr. Emsellem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel . The institution of Dr. Emsellem has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips Respironics. The institution of Dr. Emsellem has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NLS Pharma. The institution of Dr. Emsellem has received research support from ApniMed. The institution of Dr. Emsellem has received research support from Axsome. The institution of Dr. Emsellem has received research support from Balance. The institution of Dr. Emsellem has received research support from Expansion. The institution of Dr. Emsellem has received research support from Avadel (Flamel). The institution of Dr. Emsellem has received research support from Harmony. The institution of Dr. Emsellem has received research support from Idorsia. The institution of Dr. Emsellem has received research support from Imbrium. The institution of Dr. Emsellem has received research support from Jazz. The institution of Dr. Emsellem has received research support from Merck. The institution of Dr. Emsellem has received research support from NLS. The institution of Dr. Emsellem has received research support from Philips. The institution of Dr. Emsellem has received research support from Suven. The institution of Dr. Emsellem has received research support from Takeda. The institution of Dr. Emsellem has received research support from Vanda. |
| Louis J. Ptacek, MD | Dr. Ptacek has nothing to disclose. |
| Flavia B. Consens, MD | Dr. Consens has nothing to disclose. |
| Joyce K. Lee-Iannotti, MD, FAAN | Dr. Lee-Iannotti has nothing to disclose. |